Counsel & Heal |
Early surgery offers long-term survival, lowers risk of heart failure in …
News-Medical.net Patients with severe mitral valve regurgitation who are otherwise healthy should have mitral valve repair surgery sooner rather than later, even if they feel no symptoms, a Mayo Clinic-led study by U.S. and European researchers found. The results … Early Surgery: A Better Option for People With Severe Mitral Valve RegurgitationCounsel & Heal |
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free … – NASDAQ
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free …NASDAQMORRIS PLAINS, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) –Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal ant…
New Scoring System Evaluates Prognosis in Burkitt Lymphoma – Medscape
MedscapeNew Scoring System Evaluates Prognosis in Burkitt LymphomaMedscapeAdding rituximab to chemotherapy has improved both response and survival rates, but that has been difficult to conclusively demonstrate in small, single-arm, single-institution s…
Youth Migration And Implication – P.M. News
|
Youth Migration And Implication
P.M. News But as good and legal as travelling out is, it is expedient and necessary for everyone planning to travel to go with all the necessary papers, and most importantly to commit his journey into God’s hand. There are some bad reasons why … The main … |
IMMUNOMEDICS, INC. : EPRATUZUMAB AND RITUXIMAB PRODUCE HIGH … – 4-traders (press release)
IMMUNOMEDICS, INC. : EPRATUZUMAB AND RITUXIMAB PRODUCE HIGH …4-traders (press release)based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the combination of epratuzumab and rituximab, as a …
Grapefruit may be heart's best friend – Times of India
|
Grapefruit may be heart’s best friend
Times of India The study, which was carried out by the researchers from Glasgow University, has found out that biomolecules could be used to reduce the inflammation that is the main cause of various heart problems, the Daily Express reported. This research may give … |
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free … – Wall Street Journal
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free …Wall Street JournalMORRIS PLAINS, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of …
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free … – GlobeNewswire (press release)
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free …GlobeNewswire (press release)MORRIS PLAINS, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) — Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the devel…
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free … – MarketWatch
Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free …MarketWatchImmunomedics, Inc. (NASDAQ:IMMU) , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment …
Special Forces in massive blood donation… – New Vision
New VisionSpecial Forces in massive blood donation…New VisionThe Special Forces Command (SFC) has embarked on a massive blood donation drive to shore up national blood reserves. Hundreds officers attached to SFC and their families are expected to tak…